Next Phase Research is a leading research service provider, sometimes referred to as a contract research organization (CRO). We offer innovative late-phase research solutions that provide scientific and medical evidence to support the commercialization of medical products. Our services include strategic consulting, market research and intelligence, late-phase research (patient registries, peri-approval and post-approval clinical trials), and medical communications.

GynexGroup, Inc. is a privately held company founded to research and develop fragrance products that employ techniques that stimulate the vomeronasal organ as well as the typical olfactory receptors. Combining the emotional reactions evoked by fine perfumes with the more primal reactions naturally caused by human pheromones was achieved by bringing together the science of psychoneuroendocrinology and the art of fine perfuming. At our state-of-the-art research and development laboratory in the Denver Technology Center in Colorado, our psychoneuroendocrinology scientists works closely with our in-house master perfumer to use our proprietary blends of synthesized human pheromone molecules as integral elements of the fragrance design palette. Our patented TriActive Bio-Sense Stimulation technology evokes cognitive and emotional guidance through simultaneous stimulation of the primary olfactory receptor neurons and the auxiliary vomeronasal organ (VNO) which results in enhanced physiologic reactions in men and women. Our SpellboundRX brand develops and markets a full line of pheromone-based fragrance products for men and women. The GynexGroup, Inc, corporate Headquarters is located at 244 Madison Avenue, New York, NY. Our 35,000 square foot Research & Development Laboratory is located in the Denver Technological Center at 4600 S. Syracuse Street, Denver, CO. Our state-of-the-art Processing and production facility is located at PO Box 3977, Parker, CO

We also assist clients in rapidly developing, manufacturing and commercializing point of care lateral flow, flow through and ELISA assays for any market segment. We develop using fluorescent, visual colloidal gold and paramagnetic labels,and high sensitivity, quantitative and reader-based tests are our specialty. With the decades of experiences and our unique technologies, Creative Diagnostics prides itself on its commitment to providing its customers in research and industry the highest quality products and services.